Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Surgery to improve liver function in cirrhosis patients

Official title: The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on Liver Reserve Function for Cirrhosis Patients

Run by Northern Jiangsu People's Hospital · NCT05325437 · Data updated 2026-11-12

This study tests whether a specific surgery can help improve liver function in patients with cirrhosis who have an enlarged spleen.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorNorthern Jiangsu People's Hospital
Academic / other
Locations1 site (Yangzhou, Jiangsu)
StatusRecruiting
StartedMarch 1, 2022
Main results expectedJuly 31, 2025
Study endsJuly 31, 2025
Registry record updatedMay 30, 2025
Trial IDNCT05325437 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients diagnosed with cirrhosis who have splenomegaly and secondary hypersplenism.

Probably not a fit

Patients with hepatocellular carcinoma, Child-Pugh grade C, or other significant comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of laparoscopic splenectomy and azygoportal disconnection on liver reserve function in patients with cirrhosis. Patients diagnosed with cirrhosis and experiencing splenomegaly and secondary hypersplenism will undergo the surgical procedure, followed by a standardized postoperative treatment plan. Liver function indicators will be monitored at various intervals post-surgery to assess improvements in liver reserve function and overall patient prognosis.

Why it matters

Potential benefit: If successful, this approach could enhance liver function and improve outcomes for patients with cirrhosis.

How similar studies have gone: While similar surgical approaches have been explored, this specific combination of procedures and its effects on liver reserve function is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* A clinical, radiological or histologic diagnosis of cirrhosis of any etiology
* Splenomegaly with secondary hypersplenism
* gastroesophageal variceal bleeding
* Informed consent to participate in the study

Exclusion Criteria:

* Hepatocellular carcinoma or any other malignancy,
* Child-Pugh grade C
* Recent peptic ulcer disease
* History of Hemorrhagic stroke
* Pregnancy.
* Uncontrolled Hypertension
* Human immunodeficiency virus (HIV) infection

Where it's running

  • Clinical Medical College of Yangzhou University
    Yangzhou, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.